跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METHYLPHENIDATE SANDOZ XR methylphenidate hydrochloride 36 mg modified release tablet, bottle - TGA Drug Approval Details
Approvals
/
TGA
/
METHYLPHENIDATE SANDOZ XR methylphenidate hydrochloride 36 mg modified release tablet, bottle
Approved
STANDARD
METHYLPHENIDATE SANDOZ XR methylphenidate hydrochloride 36 mg modified release tablet, bottle
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
c06e34b0f1ede76e
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
c06e34b0f1ede76e
Product Name
METHYLPHENIDATE SANDOZ XR methylphenidate hydrochloride 36 mg modified release tablet, bottle
Artg Id
453509
Artg Name
METHYLPHENIDATE SANDOZ XR methylphenidate hydrochloride 36 mg modified release tablet, bottle
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2025-05-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
c06e34b0f1ede76e
Type
Standard
Back to TGA Approvals
